Bulimia Nervosa Clinical Trial
Official title:
Targeting Inhibitory Control Using Computerised Training Among Patients With Bulimia Nervosa and Binge Eating Disorder
This research project aims to explore the feasibility of a computerised training to reduce
approach to high energy-dense foods among individuals who binge eat. The computerised
intervention used will be an inhibitory control training, particularly, a food-specific
go/no-go task. Eighty adults with a diagnosis of bulimia nervosa or binge eating disorder who
are currently receiving psychological and/or pharmacological treatment for their eating
disorder will be recruited and randomised to receive the computerised training in addition to
treatment as usual (experimental group: training + TAU) or treatment as usual only (control
group: TAU). Participants will complete questionnaires at baseline (T0), post-intervention
(T1; 4 weeks), and follow-up (T2; 8 weeks).
Participants will be asked to complete the computerised training for 4 weeks using a mobile
app called FoodT. The computerised training consists of completing a food-specific go/no-go
task to reduce approach to high energy-dense foods.
The results of this study will build steps for future larger-scale interventions and improve
understanding of psychological mechanisms involved in binge eating behaviour.
Status | Recruiting |
Enrollment | 80 |
Est. completion date | January 1, 2021 |
Est. primary completion date | September 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: 1. A diagnosis of bulimia nervosa or binge eating disorder 2. Age 18-60 years old 2) BMI = 18.5 3) Fluency in English Exclusion criteria: 1. A diagnosis of psychosis 2. A visual impairment that cannot be corrected by glasses or lenses 3. Cognitive or neurological impairment 4. Drug or alcohol abuse |
Country | Name | City | State |
---|---|---|---|
United Kingdom | King's College London | London |
Lead Sponsor | Collaborator |
---|---|
King's College London | University of Exeter |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Exploratory: Changes in Depression | The aim of this experimental outcome is to explore whether individuals in the experimental group (training + TAU) will show reductions in depression (as measured using the Patient Health Questionnaire- 9), and if so, whether the reduction is greater than that found among participants in the control group (TAU). The total score can range from 0-27, with greater scores indicating greater levels of depression. | Measured at baseline, at 4 weeks (post-intervention), and at 8 weeks (follow-up). | |
Other | Exploratory: Changes in Anxiety | The aim of this experimental outcome is to explore whether individuals in the experimental group (training + TAU) will show reductions in anxiety (as measured by the Generalised Anxiety Disorder-7), and if so, whether the reduction is greater than that found among participants in the control group (TAU). The total score can range from 0-21, with higher scores indicating greater levels of anxiety. | Measured at baseline, at 4 weeks (post-intervention), and at 8 weeks (follow-up). | |
Primary | Feasibility of intervention | Feasibility as defined by: 1) the recruitment of 75% of the target number (N = 80), 2) participants' adherence to the training task, with = 75% of participants completing at least 8 training sessions, and 3) participants' retention in treatment, with = 80% of the sample completing the end of training measures. | At 4 weeks. | |
Primary | Acceptability of intervention | Feedback forms will be used to assess the acceptability of the training, including participants' view of the helpfulness, practicality, and potential improvements to it. | Feedback forms will be completed 8 weeks post-randomisation (at follow-up). | |
Primary | Acceptability of intervention | Focus groups will be used to assess the acceptability of the training, including participants' view of the helpfulness, practicality, and potential improvements to it. | Focus groups will be conduced 2 weeks after recruitment has ended. | |
Primary | Efficacy: Changes in Binge Eating Frequency | The primary outcome aim is to examine the efficacy of app-based food-specific go/no-go training in targeting binge-eating frequency (as measured using item #13 on the Eating Disorder Examination Questionnaire). It is hypothesised that participants would exhibit reductions in binge eating frequency, with stronger effects in the experimental group (training + TAU) compared to the control (TAU) group. Participants are free to enter any numerical value, with a greater value indicating a higher frequency of binge eating. | Measured at baseline, at 4 weeks, and at 8 weeks (follow-up). | |
Secondary | Efficacy: Changes in Eating Disorder Psychopathology | The aim of this secondary outcome is to examine the efficacy of app-based food-specific go/no-go training in targeting eating disorder psychopathology (as measured using the Global Eating Disorder Examination Questionnaire score). It is hypothesised that participants will exhibit reductions in these outcomes, with stronger effects in the experimental group (training + TAU) compared to the control (TAU) group. The mean score can range from 0-6, with higher scores indicating higher eating disorder psychopathology. | Measured at baseline, at 4 weeks (post-intervention), and at 8 weeks (follow-up). | |
Secondary | Efficacy: Changes in High Energy-Dense Food Valuation | The aim of this secondary outcome is to examine the efficacy of app-based food-specific go/no-go training in targeting high energy-dense food valuation (as measured using the Food Rating Test). It is hypothesised that participants will exhibit reductions in these outcomes, with stronger effects in the experimental group (training + TAU) compared to the control (TAU) group. The mean score can range from 0-100, with higher scores indicating greater high energy-dense food valuation. | Measured at baseline, at 4 weeks (post-intervention), Measured at baseline, at 4 weeks (post-intervention), and at 8 weeks (follow-up). | |
Secondary | Efficacy: Changes in Food Approach | The aim of this secondary outcome is to examine the efficacy of app-based food-specific go/no-go training in targeting food approach (as measured using the Adult Eating Behaviour Questionnaire, food approach sub scale). It is hypothesised that participants will exhibit reductions in these outcomes, with stronger effects in the experimental group (training + TAU) compared to the control (TAU) group. Participant responses range from 1-5, ranging from strongly disagree to strongly agree. Higher scores indicate greater food approach behaviour. | Measured at baseline, at 4 weeks (post-intervention), and at 8 weeks (follow-up). | |
Secondary | Efficacy: Changes in Food Addiction | The aim of this secondary outcome is to examine the efficacy of app-based food-specific go/no-go training in targeting food addiction (as measured using the Yale Food Addiction Scale). It is hypothesised that participants will exhibit reductions in these outcomes, with stronger effects in the experimental group (training + TAU) compared to the control (TAU) group. The mean score can range from 0-4, with higher scores indicating greater food addiction. | Measured at baseline, at 4 weeks (post-intervention), and at 8 weeks (follow-up). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04174703 -
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
|
N/A | |
Terminated |
NCT04278755 -
Binge Eating & Birth Control
|
Phase 2 | |
Withdrawn |
NCT02978742 -
Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder
|
N/A | |
Withdrawn |
NCT00988481 -
Topiramate Augmentation in Bulimia Nervosa Partial Responders
|
Phase 4 | |
Completed |
NCT00184301 -
A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.
|
N/A | |
Completed |
NCT00522769 -
Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents
|
Phase 1/Phase 2 | |
Completed |
NCT00304187 -
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
|
Phase 2 | |
Recruiting |
NCT04409457 -
Self-Control in Bulimia Nervosa
|
N/A | |
Recruiting |
NCT05509257 -
Naltrexone Neuroimaging in Teens With Eating Disorders
|
Early Phase 1 | |
Recruiting |
NCT05862389 -
Study on the Mechanism of Eating Disorder
|
||
Recruiting |
NCT05937243 -
Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating
|
N/A | |
Recruiting |
NCT05728021 -
Smartphone-based Aftercare for Inpatients With Bulimia Nervosa
|
N/A | |
Completed |
NCT03781921 -
The Neural Bases of Emotion Regulation in Bulimia Nervosa
|
||
Completed |
NCT02553824 -
FDA Approved Medication to Reduce Binge Eating and/or Purging
|
Phase 1 | |
Terminated |
NCT04041024 -
Decision-making and Risk-taking in Bulimia
|
N/A | |
Completed |
NCT04265131 -
Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome?
|
N/A | |
Recruiting |
NCT06431854 -
Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
|
N/A | |
Recruiting |
NCT02960152 -
Periodontal Impact of Eating Disorders (the PERIOED Study)
|
N/A | |
Completed |
NCT00916071 -
Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders
|
N/A | |
Terminated |
NCT00308776 -
Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
|
N/A |